Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

A prospective evaluation of the predictive value of faecal calprotectin in quiescent Crohn's disease.

Naismith GD, Smith LA, Barry SJ, Munro JI, Laird S, Rankin K, Morris AJ, Winter JW, Gaya DR.

J Crohns Colitis. 2014 Sep 1;8(9):1022-9. doi: 10.1016/j.crohns.2014.01.029. Epub 2014 Feb 22.

PMID:
24566170
[PubMed - in process]
2.

Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study.

Kallel L, Ayadi I, Matri S, Fekih M, Mahmoud NB, Feki M, Karoui S, Zouari B, Boubaker J, Kaabachi N, Filali A.

Eur J Gastroenterol Hepatol. 2010 Mar;22(3):340-5. doi: 10.1097/MEG.0b013e32832bab49.

PMID:
19581809
[PubMed - indexed for MEDLINE]
3.

A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease.

Naismith GD, Smith LA, Barry SJ, Munro JI, Laird S, Rankin K, Morris AJ, Winter JW, Gaya DR.

Aliment Pharmacol Ther. 2013 Mar;37(6):613-21. doi: 10.1111/apt.12221. Epub 2013 Jan 24.

PMID:
23347334
[PubMed - indexed for MEDLINE]
4.

Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease.

Costa F, Mumolo MG, Ceccarelli L, Bellini M, Romano MR, Sterpi C, Ricchiuti A, Marchi S, Bottai M.

Gut. 2005 Mar;54(3):364-8.

PMID:
15710984
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies.

Mao R, Xiao YL, Gao X, Chen BL, He Y, Yang L, Hu PJ, Chen MH.

Inflamm Bowel Dis. 2012 Oct;18(10):1894-9. doi: 10.1002/ibd.22861. Epub 2012 Jan 11.

PMID:
22238138
[PubMed - indexed for MEDLINE]
6.

Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease.

Walkiewicz D, Werlin SL, Fish D, Scanlon M, Hanaway P, Kugathasan S.

Inflamm Bowel Dis. 2008 May;14(5):669-73. doi: 10.1002/ibd.20376.

PMID:
18240279
[PubMed - indexed for MEDLINE]
7.

Fecal calprotectin levels predict the clinical course in patients with new onset of ulcerative colitis.

Lasson A, Simrén M, Stotzer PO, Isaksson S, Ohman L, Strid H.

Inflamm Bowel Dis. 2013 Mar;19(3):576-81. doi: 10.1097/MIB.0b013e31827e78be.

PMID:
23377170
[PubMed - indexed for MEDLINE]
8.

Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control.

van Rheenen PF.

Inflamm Bowel Dis. 2012 Nov;18(11):2018-25. doi: 10.1002/ibd.22896. Epub 2012 Jan 24.

PMID:
22275341
[PubMed - indexed for MEDLINE]
9.

Serum calprotectin as a biomarker for Crohn's disease.

Meuwis MA, Vernier-Massouille G, Grimaud JC, Bouhnik Y, Laharie D, Piver E, Seidel L, Colombel JF, Louis E; GETAID (Groupe d'Étude Thérapeutique Des Affections Inflammatoires Digestives).

J Crohns Colitis. 2013 Dec 15;7(12):e678-83. doi: 10.1016/j.crohns.2013.06.008. Epub 2013 Jul 9.

PMID:
23845231
[PubMed - indexed for MEDLINE]
10.

Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?

Molander P, Färkkilä M, Ristimäki A, Salminen K, Kemppainen H, Blomster T, Koskela R, Jussila A, Rautiainen H, Nissinen M, Haapamäki J, Arkkila P, Nieminen U, Kuisma J, Punkkinen J, Kolho KL, Mustonen H, Sipponen T.

J Crohns Colitis. 2014 Jul 19. pii: S1873-9946(14)00209-8. doi: 10.1016/j.crohns.2014.06.012. [Epub ahead of print]

PMID:
25052347
[PubMed - as supplied by publisher]
11.

Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study.

Laharie D, Mesli S, El Hajbi F, Chabrun E, Chanteloup E, Capdepont M, Razaire S, de Lédinghen V, Zerbib F.

Aliment Pharmacol Ther. 2011 Aug;34(4):462-9. doi: 10.1111/j.1365-2036.2011.04743.x. Epub 2011 Jun 14.

PMID:
21671970
[PubMed - indexed for MEDLINE]
12.

Fecal calprotectin: a selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy.

Koulaouzidis A, Douglas S, Rogers MA, Arnott ID, Plevris JN.

Scand J Gastroenterol. 2011 May;46(5):561-6. doi: 10.3109/00365521.2011.551835. Epub 2011 Jan 27.

PMID:
21269246
[PubMed - indexed for MEDLINE]
13.

Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse.

Gisbert JP, Bermejo F, Pérez-Calle JL, Taxonera C, Vera I, McNicholl AG, Algaba A, López P, López-Palacios N, Calvo M, González-Lama Y, Carneros JA, Velasco M, Maté J.

Inflamm Bowel Dis. 2009 Aug;15(8):1190-8. doi: 10.1002/ibd.20933.

PMID:
19291780
[PubMed - indexed for MEDLINE]
14.

Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.

Ferrante M, Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D'Haens GR, van der Woude CJ, Danese S, Diamond RH, Oortwijn AF, Tang KL, Miller M, Cornillie F, Rutgeerts PJ; International Organization for the Study of Inflammatory Bowel Diseases.

Gastroenterology. 2013 Nov;145(5):978-986.e5. doi: 10.1053/j.gastro.2013.08.010. Epub 2013 Aug 14.

PMID:
23954314
[PubMed - indexed for MEDLINE]
15.

The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease.

Henderson P, Casey A, Lawrence SJ, Kennedy NA, Kingstone K, Rogers P, Gillett PM, Wilson DC.

Am J Gastroenterol. 2012 Jun;107(6):941-9. doi: 10.1038/ajg.2012.33. Epub 2012 Feb 28.

PMID:
22370604
[PubMed - indexed for MEDLINE]
16.

Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.

Yang Z, Clark N, Park KT.

Clin Gastroenterol Hepatol. 2014 Feb;12(2):253-62.e2. doi: 10.1016/j.cgh.2013.06.028. Epub 2013 Jul 21.

PMID:
23883663
[PubMed - indexed for MEDLINE]
17.

Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn's disease after ileocolonic resection: A prospective pilot study.

Yamamoto T, Shiraki M, Bamba T, Umegae S, Matsumoto K.

United European Gastroenterol J. 2013 Oct;1(5):368-74. doi: 10.1177/2050640613501818.

PMID:
24917985
[PubMed]
Free PMC Article
18.

Can calprotectin predict relapse risk in inflammatory bowel disease?

D'Incà R, Dal Pont E, Di Leo V, Benazzato L, Martinato M, Lamboglia F, Oliva L, Sturniolo GC.

Am J Gastroenterol. 2008 Aug;103(8):2007-14.

PMID:
18802997
[PubMed - indexed for MEDLINE]
19.

Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity.

Lin JF, Chen JM, Zuo JH, Yu A, Xiao ZJ, Deng FH, Nie B, Jiang B.

Inflamm Bowel Dis. 2014 Aug;20(8):1407-15. doi: 10.1097/MIB.0000000000000057.

PMID:
24983982
[PubMed - in process]
20.

Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.

Waugh N, Cummins E, Royle P, Kandala NB, Shyangdan D, Arasaradnam R, Clar C, Johnston R.

Health Technol Assess. 2013 Nov;17(55):xv-xix, 1-211. doi: 10.3310/hta17550. Review.

PMID:
24286461
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk